ArticleScientific reports2025
Breastfeeding protects against malnutrition and growth failure in children with microcephaly associated with congenital Zika syndrome.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Malnutrition in Children with Congenital Zika Virus Syndrome: A Systematic Review.Maternal and child health journal · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Congenital Zika Virus Syndrome (CZS) impacts children's physical and cognitive development, and it is still unknown how breastfeeding protects their growth. This 5-year cohort study followed children with CZS microcephaly to analyze the relationship between breastfeeding practices and the presence of malnutrition and growth failure at 6, 24, 36, 48 and 60 months. Breastfeeding was evaluated by Exclusive breastfeeding (EBF) under six months, EBF for the first two days after birth (EBF2D), long-term EBF (LTEBF, when above 3 months), short-term EBF (STEBF, when below 3 months), and continued breastfeeding 12-24 months (CBF). Malnutrition was determined by z-scores weight-for-age, length/height-for-age, and weight-for-length/height, and the presence of growth failure. Associations were explored using covariate-adjusted logistic regression equations. Malnutrition increased throughout childhood. The LTEBF reduced the risk of underweight and stunting at 24 months simultaneously (RR = 0.163; 95% CI = 0.03-0.996; p = 0.049); and children who received CBF had a lower risk of growth failure between 6 and 24 months (RR = 0.034; 95% CI = 0.0-0.52; p = 0.015). Breast milk was a protective factor against malnutrition for children with CZS, reducing the risk of underweight and stunting at 24 months and the risk of growth failure between 6 and 24 months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.